Correlation of the triglyceride-glucose index with major adverse cardiovascular events in type 2 diabetes mellitus patients with acute myocardial infarction combined with HFpEF

Correlation of the triglyceride-glucose index with major adverse cardiovascular events in type 2 diabetes mellitus patients with acute myocardial infarction combined with HFpEF

AimsThis study was conducted to evaluate the correlation between triglyceride-glucose index (TyG) and major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus (T2DM) and heart failure with preserved ejection fraction (HFpEF) after acute myocardial infarction (AMI).Methods...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaodong Zhang, Nan Niu, Shengqin Yu, Xinxin Zhang, Xuefu Chen, Ming Yu, Wenmiao Zhang, Ying Liu, Zhenwei Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Endocrinology
Subjects:	triglyceride-glucose index acute myocardial infarction heart failure with preserved ejection fraction major adverse cardiovascular events type 2 diabetes mellitus
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1585067/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnostic and therapeutic practice for HFpEF across continents and regions: An international survey
by: Inga J. Ingimarsdóttir, et al.
Published: (2025-02-01)

The correlation between lipoprotein(a) and major adverse cardiovascular events in patients with acute myocardial infarction combined with heart failure with preserved ejection fraction
by: Xiaodong Zhang, et al.
Published: (2025-06-01)

Targeting atrial fibrillation in HFpEF: the emerging role of pulsed field ablation
by: A. S. Parwani, et al.
Published: (2025-07-01)

Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study
by: Jerremy Weerts, et al.
Published: (2025-07-01)

Diabetes mellitus aggravates myocardial inflammation and oxidative stress in aortic stenosis: a mechanistic link to HFpEF features
by: Melissa Herwig, et al.
Published: (2025-05-01)

Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets
by: Simin Delalat, et al.
Published: (2025-05-01)

A two‐phase approach to identifying HFpEF in heart failure patients: Risk score evaluation and decision tree development
by: Izabella Uchmanowicz, et al.
Published: (2025-08-01)

The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF
by: Shenghua Zhou, et al.
Published: (2025-03-01)

Differences in Pulmonary Artery Flow Hemodynamics Between PAH and PH‐HFpEF: Insights From 4D‐Flow CMR
by: Bong‐Joon Kim, et al.
Published: (2025-01-01)

A predictive model for heart failure with preserved ejection fraction following acute myocardial infarction: the HFpEF-AMI score
by: Xi Wu, et al.
Published: (2025-07-01)

Targeted Overexpression of Mitochondrial ALDH2 in Coronary Endothelial Cells Mitigates HFpEF in a Diabetic Mouse Model
by: Guodong Pan, et al.
Published: (2025-07-01)

Prognostic significance of FT3 levels in hypertrophic cardiomyopathy patients with HFpEF
by: Zhen-Yu Yang, et al.
Published: (2025-08-01)

Semaglutide: an emerging treatment option for patients with obesity related HFpEF
by: Sanya Ashraf Khaskheli, et al.
Published: (2024-08-01)

The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications
by: Xiangling Duan, et al.
Published: (2025-04-01)

Alterations of myocardial ketone metabolism in heart failure with preserved ejection fraction (HFpEF)
by: Qiuyu Sun, et al.
Published: (2025-08-01)

Triglyceride-glucose index: a novel predictor of major adverse cardiovascular events and cerebrovascular events in patients with acute ST-segment elevation myocardial infarction
by: Ruibin Wei, et al.
Published: (2025-05-01)

Association of serum potassium time in target range with cardiovascular outcomes in patients with HFpEF
by: Yu Liu, et al.
Published: (2025-08-01)

Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes
by: Matilde Sbriscia, et al.
Published: (2025-03-01)

Predictive value of serum myeloperoxidase (MPO) concentration combined with triglyceride-glucose index (TyG) for major adverse cardiaovascular events (MACE) in patients with coronary heart disease
by: Adila Wulamu, et al.
Published: (2025-12-01)

Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis
by: Mingzhi Lin, et al.
Published: (2025-05-01)

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
by: Yanhua Yang, et al.
Published: (2020-01-01)

The Critical Role of Comorbidities in Managing Heart Failure with Preserved Ejection Fraction (HFpEF)
by: Piotr Gajewski, et al.
Published: (2025-06-01)

Sex differences in the association between nutritional status and in‐hospital mortality in HFpEF patients
by: Michał Czapla, et al.
Published: (2025-08-01)

Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies
by: Francesca Coppi, et al.
Published: (2025-06-01)

The effects of SGLT2i on cardiac metabolism in patients with HFpEF: Fact or fiction?
by: Francesca Cinti, et al.
Published: (2025-05-01)

Does diabetes status modify the association between the triglyceride-glucose index and major adverse cardiovascular events in patients with coronary heart disease? A systematic review and meta-analysis of longitudinal cohort studies
by: Shicong Xu, et al.
Published: (2025-08-01)

Hepatocyte growth factor and B-type natriuretic peptide as independent predictors of mortality in HFpEF patients
by: Hou-liang Chen, et al.
Published: (2025-02-01)

Association between triglyceride-glucose and triglyceride-glucose related indices with all-cause mortality in depression participants: a cohort study from NHANES
by: Xinxing Wang, et al.
Published: (2025-07-01)

Impact of SGLT2 inhibitors on myocardial fibrosis in diabetic HFpEF: a longitudinal study
by: Arif Albulushi, et al.
Published: (2025-07-01)

Novel insights into beta cell ER stress CHOP and its role in HFpEF development
by: Balaji Srinivas, et al.
Published: (2025-06-01)

Investigating the effect of SGLT2 inhibitors on cardiovascular related health status in HFmrEF and HFpEF: systematic review and meta analysis
by: Tabitha Kusi-Yeboah, et al.
Published: (2025-07-01)

Specific targeting of adipose tissue metabolism is superior to caloric restriction in treating obesity-related HFpEF
by: Simon Sedej, et al.
Published: (2025-07-01)

The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study
by: Jianyong Zhao, et al.
Published: (2025-05-01)

Effect of hyperhomocysteinemia on the prognostic value of triglyceride glucose index in patients with acute coronary syndrome
by: Yi Kan, et al.
Published: (2025-01-01)

The association of triglyceride glucose waist-to-height ratio index with depression in United States adults
by: Rangrang Zhang, et al.
Published: (2025-07-01)

Prevalence and Prognostic Value of the Novel Consensus Definition of Metabolic Hyperferritinemia in Patients With Heart Failure With Preserved Ejection Fraction Across Different Glucose Metabolism States
by: Weicheng Ni, et al.
Published: (2025-07-01)

MyoMed205 Counteracts Titin Hyperphosphorylation and the Expression of Contraction‐Regulating Proteins in a Rat Model of HFpEF
by: Beatrice Vahle, et al.
Published: (2025-06-01)

A Novel Multi-Target Approach for Cardiometabolic HFpEF: Preclinical Evidence for Semaglutide and TY1 Combination Therapy
by: Mahmoud Elbatreek, et al.
Published: (2025-06-01)

Triglyceride-glucose index is associated with lupus nephritis and gender disparity in systemic lupus erythematosus patients
by: Shuhan Lin, et al.
Published: (2025-05-01)

Association of Triglyceride‐Glucose Index, Triglyceride to High‐Density Lipoprotein Cholesterol Ratio, and Related Parameters With Prehypertension and Hypertension
by: Shijie Yang, et al.
Published: (2025-01-01)